Annual ROE
-52.79%
+11.52%+17.91%
December 31, 2023
Summary
- As of February 7, 2025, CNTA annual return on equity is -52.79%, with the most recent change of +11.52% (+17.91%) on December 31, 2023.
- During the last 3 years, CNTA annual ROE has fallen by -100.34% (-211.02%).
- CNTA annual ROE is now -211.02% below its all-time high of 47.55%, reached on December 31, 2020.
Performance
CNTA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-52.13%
+10.95%+17.36%
September 30, 2024
Summary
- As of February 7, 2025, CNTA quarterly return on equity is -52.13%, with the most recent change of +10.95% (+17.36%) on September 30, 2024.
- Over the past year, CNTA quarterly ROE has increased by +1.90% (+3.52%).
- CNTA quarterly ROE is now -6670.13% below its all-time high of -0.77%, reached on March 31, 2021.
Performance
CNTA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CNTA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.9% | +3.5% |
| 3 y3 years | -211.0% | -178.2% |
| 5 y5 years | - | -178.2% |
CNTA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +17.9% | -178.2% | +17.4% |
| 5 y | 5-year | -211.0% | +17.9% | -6670.1% | +17.4% |
| alltime | all time | -211.0% | +17.9% | -6670.1% | +17.4% |
Centessa Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -52.13%(-17.4%) |
| Jun 2024 | - | -63.08%(+12.5%) |
| Mar 2024 | - | -56.07%(-1.1%) |
| Dec 2023 | -52.79%(-17.9%) | -56.72%(+5.0%) |
| Sep 2023 | - | -54.03%(+0.1%) |
| Jun 2023 | - | -54.00%(-9.6%) |
| Mar 2023 | - | -59.74%(+11.2%) |
| Dec 2022 | -64.31% | -53.74%(+37.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -39.22%(+19.5%) |
| Jun 2022 | - | -32.83%(+27.1%) |
| Mar 2022 | - | -25.84%(+37.9%) |
| Dec 2021 | - | -18.74%(-13.1%) |
| Sep 2021 | - | -21.56%(+113.7%) |
| Jun 2021 | - | -10.09%(+1210.4%) |
| Mar 2021 | - | -0.77% |
| Dec 2020 | 47.55% | - |
FAQ
- What is Centessa Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual ROE year-on-year change?
- What is Centessa Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly ROE year-on-year change?
What is Centessa Pharmaceuticals annual return on equity?
The current annual ROE of CNTA is -52.79%
What is the all time high annual ROE for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual return on equity is 47.55%
What is Centessa Pharmaceuticals annual ROE year-on-year change?
Over the past year, CNTA annual return on equity has changed by +11.52% (+17.91%)
What is Centessa Pharmaceuticals quarterly return on equity?
The current quarterly ROE of CNTA is -52.13%
What is the all time high quarterly ROE for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly return on equity is -0.77%
What is Centessa Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, CNTA quarterly return on equity has changed by +1.90% (+3.52%)